Humana Inc (HUM · NYSE)

HUM · MARKET VIEW

Market view · as of Aug 10, 2026

Revenue (TTM)
$145.68B
+26.2% YoY
Gross margin
13.7%
EPS (latest q)
$7.61
vs $6.22 est · beat
52-wk position
90.1%
-6.0% vs 52w high · -1.8% 1mo

Price (last ~year)

Humana Inc. (HUM) reported quarterly revenue of $40.87 billion and earnings of $7.61 per share for the period ending June 30, 2026, surpassing analyst estimates of $6.22. The company maintains a $44.10 billion market capitalization and $14.25 billion in total debt, with a debt-to-EBITDA ratio of 4.0x. Shares closed at $385.00, marking a 30.7% gain over the last three months, against a backdrop of recent institutional stake reductions and a pending securities investigation.

Valuation

Market cap
$44.10B
P/E
34.35
PEG
2.181
P/B
2.406
P/S
0.317
Beta
0.74
Analyst target
$413.09

Quality & returns

Gross margin
13.7%
Operating margin
3.5%
Profit margin
0.9%
ROE
6.9%
ROA
3.9%

Price movement

Last
$385.00
1-month
-1.8%
3-month
+30.7%
RSI (14)
44
vs SMA200
+44.5%
52-wk position
90.1% -6.0% vs high

Quarterly trajectory

Revenue by quarter (oldest → newest)

QuarterRevenueOp incomeNet incomeEBITDA
2026-06-30$40.87B$1.36B$693.0M$1.31B
2026-03-31$39.65B$1.58B$1.19B$1.97B
2025-12-31$32.52B$-1.02B$-796.0M$-685.0M
2025-09-30$32.65B$108.0M$195.0M$480.0M

Recent news

Sources this view read

  • fundamentals Company overview & valuation (Alpha Vantage OVERVIEW)
  • filing Quarterly financial statements (Alpha Vantage INCOME/BALANCE/CASH)
  • earnings Reported earnings history (Alpha Vantage EARNINGS)
  • prices Adjusted daily prices (Alpha Vantage TIME_SERIES_DAILY_ADJUSTED)

Other snapshots